(2022). Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes. Diabetes Care. http://doi.org/10.2337/dc21-1113.
(2015). Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study. Diabetologia. http://doi.org/10.1007/s00125-014-3473-8.
(2017). Life Expectancy and Cause-Specific Mortality in Type 2 Diabetes: A Population-Based Cohort Study Quantifying Relationships in Ethnic Subgroups. Diabetes Care. http://doi.org/10.2337/dc16-1616.
(2019). The comorbidity burden of type 2 diabetes mellitus: patterns, clusters and predictions from a large English primary care cohort. BMC Med. http://doi.org/10.1186/s12916-019-1373-y.
(2020). Risk Factor Control and Cardiovascular Event Risk in People With Type 2 Diabetes in Primary and Secondary Prevention Settings. Circulation. http://doi.org/10.1161/circulationaha.120.046783.
(2020). Development and validation of the DIabetes Severity SCOre (DISSCO) in 139 626 individuals with type 2 diabetes: a retrospective cohort study. BMJ Open Diabetes Res Care. http://doi.org/10.1136/bmjdrc-2019-000962.
(2020). Age-, sex- and ethnicity-related differences in body weight, blood pressure, HbA(1c) and lipid levels at the diagnosis of type 2 diabetes relative to people without diabetes. Diabetologia. http://doi.org/10.1007/s00125-020-05169-6.
(2021). Body mass index and cancer mortality in patients with incident type 2 diabetes: A population-based study of adults in England. Diabetes Obes Metab. http://doi.org/10.1111/dom.14614.
(2021). Assessing the severity of cardiovascular disease in 213 088 patients with coronary heart disease: a retrospective cohort study. Open Heart. http://doi.org/10.1136/openhrt-2020-001498.